BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19069577)

  • 1. Higher rate of major depression among blood donor candidates infected with human t-cell lymphotropic virus type 1.
    Stumpf BP; Carneiro-Proietti AB; Proietti FA; Rocha FL;
    Int J Psychiatry Med; 2008; 38(3):345-55. PubMed ID: 19069577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major depression and generalized anxiety disorder among human T-lymphotropic virus types I- and II-infected former blood donors.
    Guiltinan AM; Kaidarova Z; Behan D; Marosi C; Hutching S; Kaiser M; Moore E; Devita D; Murphy EL;
    Transfusion; 2013 Jan; 53(1):60-8. PubMed ID: 22554308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors for Human T-Lymphotropic Virus Type 1 (HTLV-1) among maintenance hemodialysis patients.
    Santos RF; Conceição GC; Martins MS; Kraychete A; Penalva MA; Carvalho EM; Lopes AA; Rocha PN
    BMC Nephrol; 2017 Feb; 18(1):64. PubMed ID: 28202003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary symptoms associated with human T-cell lymphotropic virus type I infection: evidence of urinary manifestations in large group of HTLV-I carriers.
    Castro NM; Rodrigues W; Freitas DM; Muniz A; Oliveira P; Carvalho EM
    Urology; 2007 May; 69(5):813-8. PubMed ID: 17482910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher prevalence of fibromyalgia in patients infected with human T cell lymphotropic virus type I.
    Cruz BA; Catalan-Soares B; Proietti F
    J Rheumatol; 2006 Nov; 33(11):2300-3. PubMed ID: 17086610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Ratio of Human T Cell Lymphotropic Virus Transmission and Prevalence of Human T Cell Lymphotropic Virus Type 1-Associated Diseases in Brazilian Family Groups Followed Up by the GIPH Cohort.
    Romanelli LCF; Figueiredo GGR; Ribeiro MA; Martins ML
    AIDS Res Hum Retroviruses; 2024 Jun; 40(6):401-407. PubMed ID: 38299509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high prevalence of human T-lymphotropic virus type I carriers in patients with antithyroid antibodies.
    Mizokami T; Okamura K; Ikenoue H; Sato K; Kuroda T; Maeda Y; Fujishima M
    Thyroid; 1994; 4(4):415-9. PubMed ID: 7711504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T-Lymphotropic Virus Type I (HTLV-1) Infection among Iranian Blood Donors: First Case-Control Study on the Risk Factors.
    Hedayati-Moghaddam MR; Tehranian F; Bayati M
    Viruses; 2015 Nov; 7(11):5736-45. PubMed ID: 26556363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion.
    Murphy EL; Lee TH; Chafets D; Nass CC; Wang B; Loughlin K; Smith D;
    J Infect Dis; 2004 Aug; 190(3):504-10. PubMed ID: 15243924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean.
    Rouet F; Meertens L; Courouble G; Herrmann-Storck C; Pabingui R; Chancerel B; Abid A; Strobel M; Mauclere P; Gessain A
    J Clin Microbiol; 2001 Apr; 39(4):1247-53. PubMed ID: 11283036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatological manifestations in patients with human T-cell lymphotropic virus at a reference service in Amazon.
    Andrade de Sousa B; Dos Santos LV; Oliveira TR; Dias AL; Araújo da Costa C; Medeiros Sousa RC; de Sousa MS; Xavier MB
    Int J Dermatol; 2019 Aug; 58(8):953-960. PubMed ID: 30888053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep Sequencing Analysis of Human T Cell Lymphotropic Virus Type 1 Long Terminal Repeat 5' Region from Patients with Tropical Spastic Paraparesis/Human T Cell Lymphotropic Virus Type 1-Associated Myelopathy and Asymptomatic Carriers.
    Rego FF; de Oliveira T; Giovanetti M; Galvão-Castro B; Gonçalves Mde S; Alcantara LC
    AIDS Res Hum Retroviruses; 2016 Mar; 32(3):279-83. PubMed ID: 26472535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease.
    Furtado Mdos S; Andrade RG; Romanelli LC; Ribeiro MA; Ribas JG; Torres EB; Barbosa-Stancioli EF; Proietti AB; Martins ML
    J Med Virol; 2012 Apr; 84(4):664-71. PubMed ID: 22337307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HIV-1, HIV-2 and HTLV antibody, in Fortaleza, Ceara, Brazil, 1993-1994.
    Broutet N; de Queiroz Sousa A; Basilio FP; Sá HL; Simon F; Dabis F
    Int J STD AIDS; 1996; 7(5):365-9. PubMed ID: 8894828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors.
    Satake M; Yamaguchi K; Tadokoro K
    J Med Virol; 2012 Feb; 84(2):327-35. PubMed ID: 22170555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatological findings in 3 generations of a family with a high prevalence of human T cell lymphotropic virus type 1 infection in Brazil.
    Nobre V; Guedes AC; Martins ML; Barbosa-Stancioli EF; Serufo JC; Proietti FA; Ribas JG; Ferreira CE; Lambertucci JR;
    Clin Infect Dis; 2006 Nov; 43(10):1257-63. PubMed ID: 17051489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis incidence in a cohort of individuals infected with human T-lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil.
    Grassi MF; Dos Santos NP; Lírio M; Kritski AL; Chagas Almeida Mda C; Santana LP; Lázaro N; Dias J; Netto EM; Galvão-Castro B
    BMC Infect Dis; 2016 Sep; 16():491. PubMed ID: 27643609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis.
    Satake M; Iwanaga M; Sagara Y; Watanabe T; Okuma K; Hamaguchi I
    Lancet Infect Dis; 2016 Nov; 16(11):1246-1254. PubMed ID: 27567105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of HTLV-I virus in blood donors and transfusion in Mali: Implications for blood safety.
    Diarra AB; Kouriba B; Guindo A; Maiga AI; Diabaté DT; Douyon I; Diawara SI; Touré BA; Fonkoro S; Murphy EL; Diallo DA
    Transfus Clin Biol; 2014 Jun; 21(3):139-42. PubMed ID: 24948205
    [No Abstract]   [Full Text] [Related]  

  • 20. Human T-Lymphotropic Virus Type 1 and 2 Seroprevalence among first-time blood donors in Chile, 2011-2013.
    San Martín H; Balanda M; Vergara N; Valenzuela MA; Cartier L; Ayala S; Ramírez E
    J Med Virol; 2016 Jun; 88(6):1067-75. PubMed ID: 26538335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.